Biodesix, Inc. BDSX
19.84 USD -1.65 (-7.68%)
At closeNov 6, 2026, 6:32 AM EST
13.32 -6.52 -32.86%
Pre-market · Nov 6, 6:32 AM ET
19.07 Day range 21.10
5.26 52-week range 31.97
- YTD
- +191.76%
- 1 year
- +130.70%
Financial health
Altman Z-Score
-5.83 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.5×
FY 2018 5y median -2.9× FY 2025
P/S 0.6×
FY 2018 5y median 2.7× FY 2025
P/B -20.8×
FY 2018 5y median 7.3× FY 2025
P/FCF -2.2×
FY 2018 5y median -3.3× FY 2025
EV/EBITDA -4.8×
FY 2018 5y median -4.8× FY 2025
EV/Sales 1.2×
FY 2018 5y median 2.2× FY 2025
FCF Yield -46.1%
FY 2018 5y median -30.4% FY 2025
Profitability
Gross Margin 81.1%
FY 2018 5y median 73.5% FY 2025
Operating Margin -31.4%
FY 2018 5y median -75.1% FY 2025
Net Margin -39.8%
FY 2018 5y median -79.2% FY 2025
ROE 1430.6%
FY 2018 5y median -218.8% FY 2025
ROIC -38.9%
FY 2018 5y median -62.7% FY 2025
ROA -40.3%
FY 2018 5y median -52.6% FY 2025
Growth (YoY)
Revenue 24.1%
FY 2018 FY 2025
Operating Income 19.5%
FY 2018 FY 2025
EPS (diluted) 29.5%
FY 2018 FY 2025
Free Cash Flow 54.4%
FY 2018 FY 2025
Financial Health
Current Ratio 1.9×
FY 2018 5y median 1.9× FY 2025
Quick Ratio 1.9×
FY 2018 5y median 1.9× FY 2025
Debt / Equity -29.6×
FY 2018 5y median 1.5× FY 2025
Net Debt / EBITDA -2.5×
FY 2018 5y median -0.9× FY 2025
Interest Coverage -3.6×
FY 2018 5y median -4.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
